[Interaction of antirheumatic preparations with proteolytic enzymes].
D001241:Aspirin / Q000494:pharmacology; D002021:Buffers; D002070:Butadienes / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004347:Drug Interactions; D004794:Enzyme Repression / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014357:Trypsin / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D002021:Buffers; D002070:Butadienes; D014361:Trypsin Inhibitors; D002738:Chloroquine; D011239:Prednisolone; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D001241:Aspirin; D007213:Indomethacin
Vzaimodeĭstvie antirevmaticheskikh preparatov s proteoliticheskimi fermentami.